Hypophosphatasia: Clinical Trials

5 trials for Hypophosphatasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Recruiting 1
Phase 23Completed 2, Recruiting 1

Follow Hypophosphatasia: new trials by email Literature Review of Hypophosphatasia trials Research Report on Hypophosphatasia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1
ALE1, Placebo - Hypophosphatasia (HPP)
Phase 1 / Phase 2RecruitingAlesta Therapeutics1202025-09-302026-08-03
Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia
Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg - Hypophosphatasia
Phase 1 / Phase 2CompletedAM-Pharma122023-05-152025-02-27
Study of ALXN1850 in Participants With Hypophosphatasia (HPP)
ALXN1850 - Hypophosphatasia
Phase 1CompletedAlexion Pharmaceuticals, Inc.152021-09-282024-12-27
Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)
asfotase alfa - Hypophosphatasia (HPP)
Phase 1 / Phase 2CompletedAlexion Pharmaceuticals, Inc.112008-09-012019-04-01
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Asfotase Alfa - Hypophosphatasia (HPP)
Phase 1CompletedAlexion Pharmaceuticals, Inc.62008-08-012019-03-29

Narrower conditions

Bone Diseases (2)  ·  Osteomalacia (2)  ·  Rickets (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Metabolic Diseases (5)  ·  Metabolism, Inborn Errors (5)  ·  Metal Metabolism, Inborn Errors (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Avitaminosis (2)  ·  Bone Diseases, Metabolic (2)  ·  Calcium Metabolism Disorders (2)  ·  Deficiency Diseases (2)  ·  Malnutrition (2)  ·  Musculoskeletal Diseases (2)  ·  Nutrition Disorders (2)  ·  Vitamin D Deficiency (2)

Interventions

asfotase alfa (2)

Sponsors

Alexion Pharmaceuticals, Inc. (3)  ·  AM-Pharma (1)  ·  Alesta Therapeutics (1)

Countries

United States (3)  ·  Canada (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  New Zealand (1)  ·  United Arab Emirates (1)

Results publications

PMID 22397652, PMID 26529632, PMID 32762706, PMID 39135540, PMID 41378916